HIGHLIGHTS
- who: Carmela Ciardullo et al. from the Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, National Horizons Centre, Teesside University, Darlington , HG, UK have published the research: Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia, in the Journal: (JOURNAL)
- what: Taken together, our data for the first time demonstrate BACH2 as a possible independent, integrative predictor of outcome in CLL.
SUMMARY
Chronic lymphocytic leukaemia (CLL) is the most prevalent leukaemia among elderly people in Western countries, showing highly variable outcomes. In GC B-cells, both . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.